By Himank Sharma MUMBAI (Reuters) - The president of an Indian brokerage association plans to formally ask the domestic market regulator to investigate trading in drugmaker Ranbaxy Laboratories Ltd's shares in the days leading up to the announcement that it will be acquired by rival Sun Pharmaceutical Industries Ltd. Ranbaxy shares surged 24 percent while trading volumes tripled in the three trading sessions before Sun Pharma said it had agreed to buy Ranbaxy for $3.2 billion. "Because there was such kind of price movement before the deal was announced, we have decided to check with the regulator," Naresh Tejwani, president of the Association of National Exchanges Members of India (ANMI) said on Wednesday, referring to the Securities and Exchange Board of India (SEBI). "We will write to them by the end of the day to investigate into the matter." Spokesmen for SEBI and Ranbaxy declined to comment on the ANMI president's statement.
via Health News Headlines - Yahoo News http://ift.tt/1k2TliO
No comments:
Post a Comment